UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 118

Sortiert nach

Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis

Cancer cell, 2015-05, Vol.27 (5), p.682-697

2015

Volltextzugriff (PDF)

Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically

Cancer immunology research, 2019-07, Vol.7 (7), p.1064-1078

2019

Volltextzugriff (PDF)

DNA-PK inhibition extends the therapeutic effects of Top2 poisoning to non-proliferating cells, increasing activity at a cost

Scientific reports, 2023-08, Vol.13 (1), p.12429-12429, Article 12429

2023

Volltextzugriff (PDF)

The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association

Clinical cancer research, 2015-08, Vol.21 (15), p.3428-3435

2015

Volltextzugriff (PDF)

Endothelial Sash1 Is Required for Lung Maturation through Nitric Oxide Signaling

Cell reports (Cambridge), 2019-05, Vol.27 (6), p.1769-1780.e4

2019

Volltextzugriff (PDF)

Differentiation of vascular smooth muscle cells from local precursors during embryonic and adult arteriogenesis requires Notch signaling

Proceedings of the National Academy of Sciences - PNAS, 2012-05, Vol.109 (18), p.6993-6998

2012

Volltextzugriff (PDF)

Limited Tissue Penetration of Taxanes: A Mechanism for Resistance in Solid Tumors

Clinical cancer research, 2007-05, Vol.13 (9), p.2804-2810

2007

Volltextzugriff (PDF)

A Low Carbohydrate, High Protein Diet Slows Tumor Growth and Prevents Cancer Initiation

Cancer research (Chicago, Ill.), 2011-07, Vol.71 (13), p.4484-4493

2011

Volltextzugriff (PDF)

SHIP Represses the Generation of Alternatively Activated Macrophages

Immunity (Cambridge, Mass.), 2005-10, Vol.23 (4), p.361-374

2005

Volltextzugriff (PDF)

Loss of the Notch effector RBPJ promotes tumorigenesis

The Journal of experimental medicine, 2015-01, Vol.212 (1), p.37-52

2015

Volltextzugriff (PDF)

Drug penetration in solid tumours

Nature reviews. Cancer, 2006-08, Vol.6 (8), p.583-592

2006

Volltextzugriff (PDF)

Direct Visualization of Heterogeneous Extravascular Distribution of Trastuzumab in Human Epidermal Growth Factor Receptor Type 2 Overexpressing Xenografts

Clinical cancer research, 2008-04, Vol.14 (7), p.2171-2179

2008

Volltextzugriff (PDF)

Targeting Quiescent Tumor Cells via Oxygen and IGF-I Supplementation

Cancer research (Chicago, Ill.), 2012-02, Vol.72 (3), p.801-809

2012

Volltextzugriff (PDF)

Vascularization predicts overall survival and risk of transformation in follicular lymphoma

Haematologica (Roma), 2010-12, Vol.95 (12), p.2157-2160

2010

Volltextzugriff (PDF)

Opposing roles for CD34 in B16 melanoma tumor growth alter early stage vasculature and late stage immune cell infiltration

PloS one, 2011-04, Vol.6 (4), p.e18160-e18160

2011

Volltextzugriff (PDF)

Targeting the tumour vasculature: exploitation of low oxygenation and sensitivity to NOS inhibition by treatment with a hypoxic cytotoxin

PloS one, 2013-10, Vol.8 (10), p.e76832

2013

Volltextzugriff (PDF)

Angiopoietin-2 Functions as a Tie2 Agonist in Tumor Models, Where It Limits the Effects of VEGF Inhibition

Cancer research (Chicago, Ill.), 2013, Vol.73 (1), p.108-118

2013

Volltextzugriff (PDF)

Multi‐modal magnetic resonance imaging and histology of vascular function in xenografts using macromolecular contrast agent hyperbranched polyglycerol (HPG‐GdF)

Contrast media and molecular imaging, 2016-01, Vol.11 (1), p.77-88

2016

Volltextzugriff (PDF)

Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK)

Molecular cancer therapeutics, 2008-01, Vol.7 (1), p.59-70

2008

Volltextzugriff (PDF)

Irinophore C, a Novel Nanoformulation of Irinotecan, Alters Tumor Vascular Function and Enhances the Distribution of 5-Fluorouracil and Doxorubicin

Clinical cancer research, 2008-11, Vol.14 (22), p.7260-7271

2008

Volltextzugriff (PDF)

The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity

BMC cancer, 2011-10, Vol.11 (1), p.420-420, Article 420

2011

Volltextzugriff (PDF)

Detection of FLASH-radiotherapy tissue sparing in a 3D-spheroid model using DNA damage response markers

Radiotherapy and oncology, 2024-07, Vol.196, p.110326-110326, Article 110326

2024

Volltextzugriff (PDF)

DNA-PK inhibitor AZD7648 is a more portent radiosensitizer than PARP inhibitor Olaparib in BRCA1/2 deficient tumors

DNA repair, 2024-07, Vol.139, p.103689, Article 103689

2024

Volltextzugriff (PDF)

Fast and sensitive dynamic oxygen‐enhanced MRI with a cycling gas challenge and independent component analysis

Magnetic resonance in medicine, 2019-04, Vol.81 (4), p.2514-2525

2019

Volltextzugriff (PDF)

Identification of breast cancer cell subtypes sensitive to ATG4B inhibition

Oncotarget, 2016-10, Vol.7 (41), p.66970-66988

2016

Volltextzugriff (PDF)

1 – 25 von 118

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(115)
Mit Volltextzugriff
(113)

Publikationsform

Sprache

Englisch
(118)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Science & Technology
(71)
Life Sciences & Biomedicine
(66)
Animals
(54)
Mice
(47)
Oncology
(46)
Humans
(43)
Female
(33)
Biological And Medical Sciences
(29)
Tumors
(26)
Medical Sciences
(24)
Radiology, Nuclear Medicine & Medical Imaging
(17)
Antineoplastic Agents
(16)
Cell Line, Tumor
(14)
Pharmacology. Drug Treatments
(14)
Mice, Scid
(13)
Xenograft Model Antitumor Assays
(13)
Male
(12)
Mice, Inbred Nod
(10)
Hypoxia
(9)
Neoplasm Transplantation
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Translational Activation of HIF1α by YB-1 Promotes Sarcoma Metastasis

Targeting Hypoxia-Induced Carbonic Anhydrase IX Enhances Immune-Checkpoint Blockade Locally and Systemically

DNA-PK inhibition extends the therapeutic effects of Top2 poisoning to non-proliferating cells, increasing activity at a cost

The Prognostic Impact of CD163-Positive Macrophages in Follicular Lymphoma: A Study from the BC Cancer Agency and the Lymphoma Study Association

Endothelial Sash1 Is Required for Lung Maturation through Nitric Oxide Signaling

Differentiation of vascular smooth muscle cells from local precursors during embryonic and adult arteriogenesis requires Notch signaling

Limited Tissue Penetration of Taxanes: A Mechanism for Resistance in Solid Tumors

A Low Carbohydrate, High Protein Diet Slows Tumor Growth and Prevents Cancer Initiation

SHIP Represses the Generation of Alternatively Activated Macrophages

Loss of the Notch effector RBPJ promotes tumorigenesis

Drug penetration in solid tumours

Direct Visualization of Heterogeneous Extravascular Distribution of Trastuzumab in Human Epidermal Growth Factor Receptor Type 2 Overexpressing Xenografts

Targeting Quiescent Tumor Cells via Oxygen and IGF-I Supplementation

Vascularization predicts overall survival and risk of transformation in follicular lymphoma

Opposing roles for CD34 in B16 melanoma tumor growth alter early stage vasculature and late stage immune cell infiltration

Targeting the tumour vasculature: exploitation of low oxygenation and sensitivity to NOS inhibition by treatment with a hypoxic cytotoxin

Angiopoietin-2 Functions as a Tie2 Agonist in Tumor Models, Where It Limits the Effects of VEGF Inhibition

Multi‐modal magnetic resonance imaging and histology of vascular function in xenografts using macromolecular contrast agent hyperbranched polyglycerol (HPG‐GdF)

Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK)

Irinophore C, a Novel Nanoformulation of Irinotecan, Alters Tumor Vascular Function and Enhances the Distribution of 5-Fluorouracil and Doxorubicin

The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity

Detection of FLASH-radiotherapy tissue sparing in a 3D-spheroid model using DNA damage response markers

DNA-PK inhibitor AZD7648 is a more portent radiosensitizer than PARP inhibitor Olaparib in BRCA1/2 deficient tumors

Fast and sensitive dynamic oxygen‐enhanced MRI with a cycling gas challenge and independent component analysis

Identification of breast cancer cell subtypes sensitive to ATG4B inhibition

Suchergebnisse filtern